Ascendis Pharma A (ASND) Assets Average (2013 - 2026)

Ascendis Pharma A (ASND) has 13 years of Assets Average data on file, last reported at $1.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 13.75% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (down 13.75% YoY), and the FY2025 full-year result was $2.5 billion, up 14.5% from the prior year.
• Assets Average climbed to $1.9 billion in Q1 2026, from $1.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.3 billion in Q4 2024 to a low of $844.2 million in Q2 2024.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average slumped 43.91% in 2023 and surged 154.39% in 2025, its largest moves.
• Tracing ASND's Assets Average over 5 years: stood at $1.2 billion in 2022, then retreated by 23.25% to $919.4 million in 2023, then soared by 148.1% to $2.3 billion in 2024, then sank by 37.17% to $1.4 billion in 2025, then surged by 34.73% to $1.9 billion in 2026.
• Business Quant data shows ASND's Assets Average at $1.9 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.3 billion in Q3 2025.